These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18974557)

  • 1. Autoimmune disorders of the neuromuscular junction.
    Vincent A
    Neurol India; 2008; 56(3):305-13. PubMed ID: 18974557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular junction disorders.
    Verschuuren J; Strijbos E; Vincent A
    Handb Clin Neurol; 2016; 133():447-66. PubMed ID: 27112691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of disorders of neuromuscular transmission.
    Vincent A
    Acta Neurol Scand Suppl; 2006; 183():1-7. PubMed ID: 16637918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to ion channels at the neuromuscular junction.
    Lang B; Vincent A
    Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic Paraneoplastic Disorders of the Neuromuscular Junction: An Update.
    Giannoccaro MP; Avoni P; Liguori R
    Brain Sci; 2021 Aug; 11(8):. PubMed ID: 34439654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myasthenia gravis and myasthenic syndromes].
    Marouf W; Sieb JP
    Z Rheumatol; 2009 Aug; 68(6):465-70. PubMed ID: 19609783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System.
    Vincent A
    Neuroscience; 2020 Jul; 439():48-61. PubMed ID: 32194225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].
    Takamori M
    Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging diversity of neuromuscular junction disorders.
    Newsom-Davis J
    Acta Myol; 2007 Jul; 26(1):5-10. PubMed ID: 17915563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Channelopathies at Neuromuscular Junction.
    Huang K; Luo YB; Yang H
    Front Neurol; 2019; 10():516. PubMed ID: 31156543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Lisý L
    Bratisl Lek Listy; 1997 Apr; 98(4):217-20. PubMed ID: 9264830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
    Vincent A; Beeson D; Lang B
    Eur J Biochem; 2000 Dec; 267(23):6717-28. PubMed ID: 11082182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia and related disorders of the neuromuscular junction.
    Spillane J; Beeson DJ; Kullmann DM
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):850-7. PubMed ID: 20547629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurophysiologic assessment of disorders affecting the neuromuscular junction].
    Kuwabara S
    Brain Nerve; 2011 Jul; 63(7):713-7. PubMed ID: 21747141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of neuromuscular junction ion channels.
    Boonyapisit K; Kaminski HJ; Ruff RL
    Am J Med; 1999 Jan; 106(1):97-113. PubMed ID: 10320124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
    Vernino S; Lennon VA
    Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.